FDA Panel: High Marks for Pfizer's Kid-Dose COVID Vaccine

(MedPage Today) -- An FDA advisory panel recommended emergency use authorization (EUA) of a two-dose regimen (10 μg apiece) of Pfizer-BioNTech's COVID-19 vaccine, administered 3 weeks apart, for children ages 5-11 years.
The Vaccines and...